Shattuck Labs, Inc. business relationships
Companies named in Shattuck Labs, Inc.’s 10-K filed 2026-03-05, and public companies whose annual reports name Shattuck Labs, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 4 / 100 Top 6% in its category
- Agent readiness
- 5 / 100
- AI adoption
- 0 / 100
Named in Shattuck Labs, Inc.’s annual report 3
“For example, we were party to collaboration agreements with Takeda Pharmaceutical Company, Ltd.("Takeda")and Ono Pharmaceutical Company, Ltd. ("Ono"), which were terminated, and will not receive any future funding under those agreements.” SEC filing
“Revenue recognized in 2024 was a result of collaboration agreements with Ono Pharmaceutical Co., Ltd ("Ono") and ImmunoGen, Inc. ("ImmunoGen").” SEC filing
“All of the Company's revenue in 2025 was derived from a license agreement with Kayak Therapeutics, Inc. ("Kayak").” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.